Advertisement

Somatic Therapies: Electroconvulsive Therapy

  • Carole Lazaro
  • Lisa A. McMurray
  • Milena Rogan Ducic
  • Timothy E. Lau
Chapter

Abstract

Electroconvulsive therapy (ECT) is a somatic treatment procedure which involves the electrical induction of seizures as a treatment for psychiatric disorders. It remains one of the safest and most effective treatments for major depressive disorder. Late-life depressive disorder responds preferentially to ECT, and its efficacy is not hampered by the presence of vascular changes in the aging brain. It is highly effective in treating major depressive disorder with psychotic features, a common presentation in older adults. ECT acts quickly to achieve remission, an attribute which makes it very useful for an older adult whose life is in danger because of refusal of food or fluids or active suicidal ideation in the context of depressive disorders, psychotic disorders, catatonia, or other psychiatric illnesses. Although ECT, with its repeated episodes of brief anesthesia, seems like a particularly assertive form of treatment, it can be safer and easier to tolerate than pharmacotherapy for a frail elder. For these reasons, ECT is an essential tool of the geriatric psychiatrist. This chapter covers the history of ECT, its mechanism of action, risks associated with use of ECT, evaluation of patients for ECT, and ECT administration technique. It also reviews relevant literature related to efficacy for various indications of use, including geriatric depressive disorders and neurological disorders such as Parkinson disease. Management of older patients following completion of a course of ECT, including the use of maintenance ECT to prevent relapse, is also reviewed. Risks and side effects of ECT, including the risk of cognitive impairment, are also discussed. Cases and multiple choice questions have been included to help the reader integrate some of the theoretical concepts into clinical strategies for patient care.

Keywords

ECT Electroconvulsive therapy Depressive disorder Aged Elderly 

References

  1. 1.
    Shorter E, Healy D. Shock therapy: a history of electroconvulsive treatment in mental illness. New Brunswick: Rutgers University Press; 2007.Google Scholar
  2. 2.
    Jenkusky SM. Public perception of electroconvulsive therapy: a historical review. Jefferson J Psychiatry. 1992;10:2–11.Google Scholar
  3. 3.
    Abrams R. Electroconvulsive therapy. 4th ed. New York: Oxford University Press; 2002.Google Scholar
  4. 4.
    Weiner RD, Rogers HJ, Davidson JR, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci. 1986;462:315–25.CrossRefPubMedGoogle Scholar
  5. 5.
    Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(2):71–83.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kellner CH. Brain stimulation in psychiatry: ECT, DBS, TMS and other modalities. Cambridge, UK: Cambridge University Press; 2012.CrossRefGoogle Scholar
  7. 7.
    Sackeim HA. Optimizing unilateral electroconvulsive therapy. Convuls Ther. 1991;7:201–12.PubMedGoogle Scholar
  8. 8.
    Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry. 1995;37(10):713–20.CrossRefPubMedGoogle Scholar
  9. 9.
    McCall WV, Farah BA, Reboussin D, Colenda CC. Comparison of the efficacy of titrated, moderate-dose and fixed, high-dose right unilateral ECT in elderly patients. Am J Geriatr Psychiatry. 1995;3:317–24.CrossRefPubMedGoogle Scholar
  10. 10.
    Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am. 1991;14(4):845–69.PubMedGoogle Scholar
  11. 11.
    American Psychiatric Association, Task Force on Electroconvulsive Therapy. The practice of ECT: recommendations for treatment, training and privileging. Convuls Ther. 1990;6(2):85–120.Google Scholar
  12. 12.
    Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry. 1983;18(11):1301–10.PubMedGoogle Scholar
  13. 13.
    Sackeim HA, Luber B, Katzman GP, et al. The effects of ECT on quantitative EEG. Relationship to clinical outcome. Arch Gen Psychiatry. 1996;53:814–24.CrossRefPubMedGoogle Scholar
  14. 14.
    Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med. 2009;360:1437–44.CrossRefPubMedGoogle Scholar
  15. 15.
    Weiner RD, Coffey CE, Krystal AD. Electroconvulsive therapy in the medical and neurologic patient. In: Stoudemire A, Fogel BS, Greenberg D, editors. Psychiatric Care of the Medical Patient. 2nd ed. New York: Oxford University Press; 2000. p. 419–28.Google Scholar
  16. 16.
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMedGoogle Scholar
  17. 17.
    Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 1995;152:995–1001.CrossRefPubMedGoogle Scholar
  18. 18.
    Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry. 2001;46(8):710–9.Google Scholar
  19. 19.
    Prudic J, Haskett RF, McCall WV, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT. 2013;29(1):3–12.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT. 2005;21(3):165–70.CrossRefPubMedGoogle Scholar
  21. 21.
    Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. J ECT. 1994;151:1657–61.Google Scholar
  22. 22.
    Post F. Affective illness. In: Arie T, editor. Recent advances in psychogeriatrics. London: Churchill Livingstone; 1992.Google Scholar
  23. 23.
    Zis AP, Goodwin FK. Major affective disorder as a recurrent illness: a critical review. Arch Gen Psychiatry. 1979;36:835–9.CrossRefPubMedGoogle Scholar
  24. 24.
    O’Connor MK, Knapp R, Husain M, et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry. 2001;9(4):382–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Sackeim HA, Rush AJ. Melancholia and response to ECT. Am J Psychiatry. 1995;152(8):1242–3.CrossRefPubMedGoogle Scholar
  26. 26.
    Weiner RD, Krystal AD. Electroconvulsive therapy. In: Gabbard GO, Rush AJ, editors. Treatments of psychiatric disorders. 3rd ed. Washington, DC: American Psychiatric Press; 2001. p. 1267–93.Google Scholar
  27. 27.
    Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53.CrossRefPubMedGoogle Scholar
  28. 28.
    Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze-Mönking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression—a randomized study. Acta Psychiatr Scand. 1997;96(5):334–42.CrossRefPubMedGoogle Scholar
  29. 29.
    Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153(8):985–92.CrossRefPubMedGoogle Scholar
  30. 30.
    Husain MM, Rush AJ, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report. J Clin Psychiatry. 2004;65(4):485–91.CrossRefPubMedGoogle Scholar
  31. 31.
    Rush AJ, Trivedi M, Fava M. Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry. 2003;160(2):237.CrossRefPubMedGoogle Scholar
  32. 32.
    Dols A, Bouckaert F, Sienaert P, et al. Early- and late-onset depression in late life: a prospective study on clinical and structural brain characteristics and response to electroconvulsive therapy. Am J Geriatr Psychiatry. 2016. pii: S1064–7481(16)30247–0.Google Scholar
  33. 33.
    Williams JH, O’Brien JT, Cullum S. Time course of response to electroconvulsive therapy in elderly depressed subjects. Int J Geriatr Psychiatry. 1997;12(5):563–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Philibert RA, Richards L, Lynch CF, Winokur G. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry. 1995;56(9):390–4.PubMedGoogle Scholar
  35. 35.
    Kellner CH, Husain MM, Knapp RG, CORE/PRIDE Work Group, et al. Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry. 2016;173(11):1101–9. appiajp201615081101CrossRefPubMedGoogle Scholar
  36. 36.
    Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2004;12(4):342–57.CrossRefPubMedGoogle Scholar
  37. 37.
    Volpe FM, Tavares AR. Lithium plus ECT for mania in 90 cases: safety issues. J Neuropsychiatry Clin Neurosci. 2012;24(4):E33.CrossRefPubMedGoogle Scholar
  38. 38.
    Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012;14(2):146–50.CrossRefPubMedGoogle Scholar
  39. 39.
    Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 2001;3(2):95–104.CrossRefPubMedGoogle Scholar
  40. 40.
    Black DW, Winokur G, Nasrallah A. ECT in unipolar and bipolar disorders: a naturalistic evaluation of 460 patients. Convuls Ther. 1986;2(4):231–7.PubMedGoogle Scholar
  41. 41.
    McCabe MS. ECT in the treatment of mania: a controlled study. Am J Psychiatry. 1976;133(6):688–91.CrossRefPubMedGoogle Scholar
  42. 42.
    Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151(2):169–76.CrossRefPubMedGoogle Scholar
  43. 43.
    Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J ECT. 2000;16(1):32–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Pompili M, Lester D, Dominici G, et al. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res. 2013;146(1–3):1–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Chanpattana W, Sackeim HA. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement. J ECT. 2010;26(4):289–98.CrossRefPubMedGoogle Scholar
  46. 46.
    Starkstein SE, Petracca G, Tesón A, et al. Catatonia in depression: prevalence, clinical correlates, validation of a scale. J Neurol Neurosurg Psychiatry. 1996;60(3):326–32.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Fink M. Delirious mania. Bipolar Disord. 1999;1(1):54–60.CrossRefPubMedGoogle Scholar
  48. 48.
    Suzuki K, Awata S, Takano T, et al. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone. Psychiatry Clin Neurosci. 2006;60(4):486–92.CrossRefPubMedGoogle Scholar
  49. 49.
    Luchini F, Lattanzi L, Bartolommei N, et al. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. J Nerv Ment Dis. 2013;201(1):36–42.CrossRefPubMedGoogle Scholar
  50. 50.
    Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci. 1997;9(2):283–92.CrossRefPubMedGoogle Scholar
  51. 51.
    Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry. 2005;76(12):1614–23.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Hausner L, Damian M, Sartorius A, Frölich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiatry. 2011;72(1):91–7.CrossRefPubMedGoogle Scholar
  53. 53.
    Liu AY, Rajji TK, Blumberger DM, Daskalakis ZJ, Mulsant BH. Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression. Am J Geriatr Psychiatry. 2014;22:216–40.CrossRefPubMedGoogle Scholar
  54. 54.
    Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev. 2010;(2):CD003690.Google Scholar
  55. 55.
    Currier MB, Murray GB, Welch CC. Electroconvulsive therapy for post-stroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci. 1992;4(2):140–4.CrossRefPubMedGoogle Scholar
  56. 56.
    Nuttall GA, Bowersox MR, Douglass SB, et al. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004;20(4):237–41.CrossRefPubMedGoogle Scholar
  57. 57.
    Mueller PS, Albin SM, Barnes RD, Rasmussen KG Jr. Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. J ECT. 2009;25(3):165–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Devanand DP, Decina P, Sackeim HA, Prudic J. Status epilepticus following ECT in a patient receiving theophylline. J Clin Psychopharmacol. 1988;8(2):153.CrossRefPubMedGoogle Scholar
  59. 59.
    Gardner BK, O’Connor DW. A review of the cognitive effects of ECT in older adults. J ECT. 2008;24:68–80.CrossRefPubMedGoogle Scholar
  60. 60.
    Dybedal G, Bjølseth TM, Benth JŠ, Tanum L. Cognitive effects of bifrontal versus right unilateral electroconvulsive therapy in the treatment of major depression in elderly patients: a randomized, controlled trial. J ECT. 2016;32:151–8.CrossRefPubMedGoogle Scholar
  61. 61.
    Fraser LM, O’Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT. 2008;24(1):10–7.CrossRefPubMedGoogle Scholar
  62. 62.
    Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55(3):301–12.CrossRefPubMedGoogle Scholar
  63. 63.
    Kellner CH. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196(3):226–34.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Devanand DP, Verma AK, Tirumalasetti F, Sackeim HA. Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry. 1991;148(7):929–32.CrossRefPubMedGoogle Scholar
  65. 65.
    Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10(2):96–104.CrossRefPubMedGoogle Scholar
  66. 66.
    van Schaik AM. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20(1):5–17.CrossRefPubMedGoogle Scholar
  67. 67.
    Shelef A, Mazeh D, Berger U, Baruch Y, Barak Y. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital readmission rates of older patients with severe mental illness. J ECT. 2015;31(2):125–8.CrossRefPubMedGoogle Scholar
  68. 68.
    Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA. 2001;285(10):1299–307.CrossRefPubMedGoogle Scholar
  69. 69.
    Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Arch Gen Psychiatry. 2006;63:1337–44.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Kellner CH, Husain MM, Knapp RG, et al.; The CORE/PRIDE Work Group. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry. 2016;173(11):1110–8. appiajp201616010118.Google Scholar
  71. 71.
    Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin Neurosci. 2005;59(4):481–9.CrossRefPubMedGoogle Scholar
  72. 72.
    Chanpattana W, Chakrabhand ML, Sackeim HA, et al. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT. 1999;15(3):178–92.CrossRefPubMedGoogle Scholar
  73. 73.
    Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depress Res Treat. 2014; 2014:135049. Published online 2014 July 21.  https://doi.org/10.1155/2014/135049.
  74. 74.
    Leth-Møller KB, Hansen AH, Torstensson M, et al. Antidepressant and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016;6(5):e011200.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Kellner CH, Greenberg RM, Murrough JW, Bryson EO, Briggs MC, Pasculli RM. ECT in treatment-resistant depression. Am J Psychiatry. 2012;169:1238–44.CrossRefPubMedGoogle Scholar
  76. 76.
    Xue Q-L. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27(1):1–15.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Casey DA, Davis MH. Electroconvulsive therapy in the very old. Gen Hosp Psychiatry. 1996;18(6):436–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Geduldig ET, Kellner CH. Electroconvulsive therapy in the elderly: new findings in geriatric depression. Curr Psychiatry Rep. 2016;18(4):40.  https://doi.org/10.1007/s11920–016–0674–5.CrossRefPubMedGoogle Scholar
  79. 79.
    Acharya D, Harper DG, Achtyes ED, et al. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Int J Geriatr Psychiatry. 2015;30:265–73.CrossRefPubMedGoogle Scholar
  80. 80.
    Sutor B, Rasmussen KG. Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008;24:239–41.CrossRefPubMedGoogle Scholar
  81. 81.
    Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry. 2014;4(1):s33–54.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Carole Lazaro
    • 1
  • Lisa A. McMurray
    • 1
  • Milena Rogan Ducic
    • 1
  • Timothy E. Lau
    • 1
  1. 1.Royal Ottawa Mental Health CentreOttawaCanada

Personalised recommendations